Rhinitis Pregnancy <2026 Release>
By understanding the causes, symptoms, and treatment options for rhinitis during pregnancy, women can take steps to manage their symptoms and prevent complications. If you are experiencing symptoms of rhinitis during pregnancy, it is essential to consult with your healthcare provider for proper diagnosis and treatment.
In addition to medical treatment, there are several natural remedies that can help alleviate symptoms of rhinitis during pregnancy:
| Condition | Distinguishing Features | |-----------|--------------------------| | Allergic rhinitis | Seasonal/perennial triggers, pruritus, positive skin prick test, eosinophils on nasal smear. | | Viral URI (common cold) | Acute onset (<2 weeks), sore throat, fever, myalgia, self-limited. | | Sinusitis | Facial pain/pressure, purulent discharge, post-viral. | | Rhinitis medicamentosa | History of topical decongestant overuse. | | Nasal polyps | Unilateral or bilateral obstruction, loss of smell (rare in pregnancy alone). | rhinitis pregnancy
Preventing and managing rhinitis during pregnancy requires a multi-faceted approach:
| Drug Class | Examples | Safety | Evidence | |------------|----------|--------|----------| | | Budesonide (Pregnancy Cat B), Fluticasone (Cat C, but widely used) | Preferred pharmacologic – minimal systemic absorption | RCTs show safety; budesonide has most pregnancy data. | | Intranasal antihistamines | Azelastine (Cat C) | Second-line | Limited data; systemic absorption low. | | Oral antihistamines (non-sedating) | Loratadine, Cetirizine (Cat B) | Reasonable for rhinorrhea/sneezing | No increased malformations in large cohort studies. | | Intranasal cromolyn sodium | Cromolyn (Cat B) | Safe but less effective | Very low absorption. | | Oral decongestants | Pseudoephedrine (Cat C) | Caution – Avoid in first trimester. Contraindicated with hypertension/pre-eclampsia. | Possible small risk of gastroschisis (first trimester). Use only short-term after 1st tri. | | Topical decongestants | Oxymetazoline (Cat C) | Avoid prolonged use (>3 days) due to rhinitis medicamentosa. | Minimal systemic absorption, but safety data sparse. | By understanding the causes, symptoms, and treatment options
Occasional nosebleeds (epistaxis) due to increased blood flow to the nasal area. Potential Risks and Impact
It typically emerges in the second or third trimester . | | Viral URI (common cold) | Acute
Risk classification (FDA/ACOG)